68/100BTeradyne stock forecast 2026–2030What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Teradyne is 445.13, 79.4% above the current price of 248.12. Their targets range from 284.00 to 550.00.
Of the 11 firms that rated Teradyne in the past 12 months, 9 rate it buy or strong buy, 2 hold and 0 sell or strong sell (each firm at its latest rating): a Strong buy consensus.
Analysts' 1-year price targets range from 284.00 to 550.00, with an average of 445.13.
| Buy | 9 | |
| Hold | 2 | |
| Sell | 0 |
12-month price target
| Highest target | 550.00 |
| Average target | 445.13 |
| Lowest target | 284.00 |
| Current price | 248.12 |
Teradyne price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Teradyne price target and rating?
How analysts rate Teradyne, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
9 of 11 firms rate it buy now, against 9 of 13 in December 2025.
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Teradyne analyst upgrades, downgrades and price targets
The latest rating change came on 21 August 2026, when Baird downgraded Teradyne from Outperform to Neutral. The most recent new target came from Jefferies on 11 November 2026: 284.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 11 Nov 2026 | Jefferies Dushyant Ailani | — | 284.00 | — | 245.40 |
| 28 Oct 2026 | Goldman Sachs | — | 465.00 → 440.00 | -5.4% | 313.24 |
| 21 Aug 2026 | Baird | Downgraded · Outperform → Neutral | — | — | — |
| 30 Jul 2026 | Morgan Stanley | Reiterated · Equal Weight | 387.00 → 397.00 | +2.6% | 361.79 |
| 30 Jul 2026 | Robert W. Baird Quinn Fredrickson | — | 446.00 → 420.00 | -5.8% | 359.71 |
| 30 Jul 2026 | Evercore ISI Vedvati Shrotre | Reiterated · Outperform | 370.00 → 420.00 | +13.5% | 357.42 |
| 28 Jul 2026 | Goldman Sachs | — | 350.00 → 465.00 | +32.9% | 320.65 |
| 20 Jul 2026 | UBS Timothy Arcuri | Reiterated · Buy | 440.00 → 500.00 | +13.6% | 340.06 |
| 30 Jun 2026 | Susquehanna | Reiterated · Positive | 415.00 → 550.00 | +32.5% | 463.21 |
| 29 Jun 2026 | Cantor Fitzgerald | Reiterated · Overweight | 400.00 → 550.00 | +37.5% | 436.86 |
| 23 Jun 2026 | Robert W. Baird | — | 350.00 → 446.00 | +27.4% | 457.00 |
| 30 Apr 2026 | Morgan Stanley Shane Brett | — | 306.00 → 387.00 | +26.5% | 351.03 |
| 30 Apr 2026 | Evercore ISI Vedvati Shrotre | Reiterated · Outperform | 430.00 → 370.00 | -14.0% | 345.57 |
| 30 Apr 2026 | Goldman Sachs | Reiterated · Buy | 300.00 → 350.00 | +16.7% | 348.74 |
| 30 Apr 2026 | Robert W. Baird | — | 305.00 → 350.00 | +14.8% | 306.33 |
| 30 Apr 2026 | JP Morgan | Upgraded · Neutral → Overweight | — | — | — |
| 28 Apr 2026 | Stifel Nicolaus Brian Chin | Reiterated · Buy | 325.00 → 390.00 | +20.0% | 402.00 |
| 27 Apr 2026 | Evercore ISI | — | 280.00 → 430.00 | +53.6% | 401.98 |
| 21 Apr 2026 | UBS | Reiterated · Buy | 275.00 → 440.00 | +60.0% | 375.21 |
| 9 Apr 2026 | Susquehanna | Reiterated · Positive | 335.00 → 415.00 | +23.9% | 364.21 |
| 9 Apr 2026 | Cantor Fitzgerald | Reiterated · Overweight | 270.00 → 400.00 | +48.1% | 364.21 |
| 11 Feb 2026 | Morgan Stanley Shane Brett | — | 288.00 → 306.00 | +6.3% | 318.09 |
| 4 Feb 2026 | Northland Securities Gus Richard | — | 186.00 → 270.00 | +45.2% | 281.29 |
| 4 Feb 2026 | Stifel Nicolaus Brian Chin | Reiterated · Buy | 280.00 → 325.00 | +16.1% | 280.38 |
| 4 Feb 2026 | Susquehanna | — | 275.00 → 335.00 | +21.8% | 279.60 |
| 4 Feb 2026 | Robert W. Baird | — | 195.00 → 305.00 | +56.4% | 282.98 |
| 3 Feb 2026 | Goldman Sachs | — | 230.00 → 300.00 | +30.4% | 282.98 |
| 3 Feb 2026 | Morgan Stanley | — | 136.00 → 288.00 | +111.8% | 282.98 |
| 3 Feb 2026 | Cantor Fitzgerald | — | 240.00 → 270.00 | +12.5% | 278.68 |
| 2 Feb 2026 | Evercore ISI | — | 280.00 | — | 246.77 |
| 2 Feb 2026 | RBC Capital | — | 270.00 | — | 252.90 |
| 30 Jan 2026 | Stifel Nicolaus | Reiterated · Buy | 270.00 → 280.00 | +3.7% | 251.87 |
| 26 Jan 2026 | UBS | Reiterated · Buy | 200.00 → 275.00 | +37.5% | 234.49 |
| 14 Jan 2026 | Stifel Nicolaus | Reiterated · Buy | 225.00 → 270.00 | +20.0% | 226.08 |
| 12 Jan 2026 | Susquehanna | — | 215.00 → 275.00 | +27.9% | 217.26 |
| 9 Jan 2026 | Vertical Research Robert Jamieson | — | 135.00 → 220.00 | +63.0% | 218.05 |
| 16 Dec 2025 | Cantor Fitzgerald | — | 180.00 → 240.00 | +33.3% | 190.54 |
| 16 Dec 2025 | Goldman Sachs | Upgraded · Sell → Buy | — | — | — |
| 15 Dec 2025 | Goldman Sachs James Schneider | — | 148.00 → 230.00 | +55.4% | 193.40 |
| 2 Dec 2025 | Stifel Nicolaus | Upgraded · Hold → Buy | 119.00 → 225.00 | +89.1% | 179.63 |
Teradyne EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Analysts expect Teradyne's EPS to grow 66.8% a year until 2028. Over the last 5 years it fell 4.1% a year, and over the last 3 years it fell 6.2%.
Analysts expect Teradyne's revenue to grow 35.7% a year until 2028, faster than over the last 5 years (0.4% a year) and the last 3 years (0.4%).
Revenue
EPS
Does Teradyne beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 17.4% off the result, either way, and their revenue estimate 4.1%, over the last 12 quarters.
- EPS beats
- 111 / 135
- Revenue beats
- 94 / 114
- Average EPS surprise, last 12What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- +17.4%
- Since
- January 1993
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 27 Oct 2026 | 2.09 | 2.29 | +9.6% | 1.27B | 1.31B | +3.0% |
| Q2 FY2026 | 28 Jul 2026 | 2.09 | 2.47 | +18.2% | 1.22B | 1.33B | +9.0% |
| Q1 FY2026 | 28 Apr 2026 | 2.11 | 2.56 | +21.3% | 1.20B | 1.28B | +6.9% |
| Q4 FY2025 | 2 Feb 2026 | 1.38 | 1.80 | +30.4% | 977.22M | 1.08B | +10.9% |
| Q3 FY2025 | 28 Oct 2025 | 0.79 | 0.85 | +7.6% | 744.13M | 769.21M | +3.4% |
| Q2 FY2025 | 29 Jul 2025 | 0.54 | 0.57 | +5.2% | 650.59M | 651.80M | +0.2% |
| Q1 FY2025 | 28 Apr 2025 | 0.62 | 0.75 | +21.2% | 680.50M | 685.68M | +0.8% |
| Q4 FY2024 | 29 Jan 2025 | 0.91 | 0.95 | +4.4% | 740.91M | 752.88M | +1.6% |
| Q3 FY2024 | 23 Oct 2024 | 0.79 | 0.90 | +13.9% | 716.40M | 737.30M | +2.9% |
| Q2 FY2024 | 24 Jul 2024 | 0.77 | 0.86 | +11.7% | 701.20M | 729.88M | +4.1% |
| Q1 FY2024 | 24 Apr 2024 | 0.33 | 0.51 | +54.5% | 566.40M | 597.54M | +5.5% |
| Q4 FY2023 | 30 Jan 2024 | 0.71 | 0.79 | +11.3% | 674.66M | 670.60M | -0.6% |
Teradyne stock price 2026–2030: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
If Teradyne's earnings grow at the 59.6% a year analysts expect to FY2028, then 15.0% a year, it would earn about 21.36 a share in FY2030. At the P/E it has traded at over the last five years (19.3 to 55.5) that is 412.78 to 1,184.62 a share, or 725.82 at its average P/E of 34.0. This is arithmetic on the analysts' estimates, not a prediction.
| Fiscal year | EPS | Bear | Base | Bull |
|---|---|---|---|---|
| FY2026 | 9.49 | 183.49 | 322.65 | 526.60 |
| FY2027 | 12.34 | 238.47 | 419.32 | 684.38 |
| FY2028 | 16.15 | 312.12 | 548.82 | 895.75 |
| FY2029 (extrapolated) | 18.57 | 358.94 | 631.15 | 1,030.11 |
| FY2030 (extrapolated) | 21.36 | 412.78 | 725.82 | 1,184.62 |
Each year's EPS is the analysts' consensus to FY2028; the years after grow 15.0% a year (the analysts' growth, at most 15%). Bear, base and bull apply the lowest, average and highest P/E of today and the last five fiscal year ends, leaving out any above 60, the mark of a year of collapsed earnings (19.3, 34.0, 55.5).
Is Teradyne stock undervalued or overvalued?How does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
Teradyne's P/E of 28.3 is around the middle of its 5-year range (14.1 to 119.8, median 27.3). It is in line with its own history. Growing 66.8% a year, Teradyne earns a P/E of 25.0 at a PEG of 1 (at most 25): × the next twelve months' EPS of 11.97, a fair value of 299.14; the price, 248.12, is 17.1% below it. Its forward P/E, on the consensus for FY2026, is 26.1.
Fair value on growth is a P/E equal to the EPS growth analysts expect a year (a PEG of 1, at most 25) times the earnings per share of the next twelve months; the ends of the bar are a PEG of 0.75 and 1.25 (a P/E of 18.8 and 31.3). The price against its P/E range
- Price to earnings ratio (TTM)What is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 28.29
- Five-year median P/EWhat is the P/E ratio? The P/E ratio divides a share's price by its earnings per share over the last year: what you pay for each dollar of profit.
- 27.33
- Five-year P/E range
- 14.1 – 119.8
- Forward P/E (FY2026)What is the forward P/E ratio? Forward P/E divides a share's price by the earnings per share analysts expect in the coming year, rather than last year's actual earnings.
- 26.13
- PEG ratioWhat is the PEG ratio? The PEG ratio divides the P/E by the yearly earnings growth analysts expect, to show how much you pay for each point of growth.
- 0.47
- To the average targetWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
- +79.4%
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.850 | 71.4258Price 35.85193 | +99.2% | |
| 29.050 | 56.2634Price 29.0596 | +93.7% | |
| 241.000 | 464.49205Price 241.00627 | +92.7% | |
| 123.590 | 237.24178Price 123.59297 | +92.0% | |
| 161.400 | 305.52159Price 161.40396 | +89.3% | |
| 157.460 | 297.58169Price 157.46471 | +89.0% | |
| 217.560 | 405.38304Price 217.56507 | +86.3% |
Furthest below the fair value on each stock's page, updated every day.